Omeprazole and Sodium Bicarbonate
- Product NDC
- 43598-307
- Requested package NDC
- 43598-307-42
- 11-digit product format
- 435980307
- Labeler code
- 43598
- Product ID
- 43598-307_dc9f1708-68a6-cb89-36c5-4e5fdb30100e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Omeprazole and Sodium Bicarbonate
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Dr. Reddy's Laboratories Inc.,
- Application
- ANDA217784
- Marketing category
- ANDA
- Marketing start
- 2024-07-15
- Substance
- OMEPRAZOLE; SODIUM BICARBONATE
- Active strength
- 20; 1680 mg/1; mg/1
- Pharmacologic classes
- Alkalinizing Activity [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | OMEPRAZOLE; SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | 1e350fbaab3a… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A217784-001 | OMEPRAZOLE AND SODIUM BICARBONATE | 20MG/PACKET;1.68GM/PACKET | FOR SUSPENSION / ORAL | 2024-05-09 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Omeprazole and Sodium Bicarbonate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OMEPRAZOLE | 20 mg/1 |
| SODIUM BICARBONATE | 1680 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| KG60484QX9 | Internal UNII lookup |
| 8MDF5V39QO | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 753562 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c6b5f808-4a49-1303-9711-badb022ecd70 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| 873ef493-6b37-49d8-ac7f-bfca4117d2c1 | Product name | 5 | 20210607 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| f33561b9-47cb-411c-a228-16c62e346cd4 | Product name | 1 | 20200415 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acid Reducer Powder | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | 6f8452f8-8c2c-6700-a11d-1531023056c5 | 2025-03-03 | Warnings | 217784 ANDA217784 |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | ddee28fb-c871-a6d4-984f-515522b28412 | 2024-07-15 | Warnings | 217784 ANDA217784 |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Dr. Reddy's Laboratories Inc., | c6b5f808-4a49-1303-9711-badb022ecd70 | 2023-07-19 | Warnings | 217784 ANDA217784 43598-307-42 43598-307 43598030742 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 753562 | omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension | PSN | c6b5f808-4a49-1303-9711-badb022ecd70 | 4 |
| 753562 | omeprazole 20 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension | SCD | c6b5f808-4a49-1303-9711-badb022ecd70 | 4 |
| 753562 | Omeprazole 20 MG / NaHCO3 1680 MG Powder for Oral Suspension | SY | c6b5f808-4a49-1303-9711-badb022ecd70 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 43598-307-42 | 43598030742 | 42 PACKET in 1 CARTON (43598-307-42) / 1 POWDER, FOR SUSPENSION in 1 PACKET | 42 packet | 2024-07-15 | No | No | Current |